Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.

Schram AM, Goto K, Kim DW, Macarulla T, Hollebecque A, O’Reilly EM, Ou SI, Rodon J, Rha SY, Nishino K, Duruisseaux M, Park JO, Neuzillet C, Liu SV, Weinberg BA, Cleary JM, Calvo E, Umemoto K, Nagasaka M, Springfeld C, Bekaii-Saab T, O’Kane GM, Opdam F, Reiss KA, Joe AK, Wasserman E, Stalbovskaya V, Ford J, Adeyemi S, Jain L, Jauhari S, Drilon A; eNRGy Investigators.

N Engl J Med. 2025 Feb 6;392(6):566-576. doi: 10.1056/NEJMoa2405008. PMID: 39908431 Clinical Trial.

https://pubmed.ncbi.nlm.nih.gov/39908431/